Cargando…
New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry
There is increasing evidence that coronavirus disease 2019 (COVID-19) may lead to new-onset diabetes mellitus (DM). This may occur even in patients without predisposing factors for impaired glucose metabolism. Both impaired pancreatic insulin secretion and insulin resistance have been implicated as...
Autores principales: | Papachristou, Stella, Stamatiou, Iliana, Stoian, Anca P., Papanas, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765692/ https://www.ncbi.nlm.nih.gov/pubmed/33367980 http://dx.doi.org/10.1007/s13300-020-00988-7 |
Ejemplares similares
-
Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?
por: Papachristou, Stella, et al.
Publicado: (2021) -
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
por: Penlioglou, Theano, et al.
Publicado: (2020) -
Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?
por: Penlioglou, Theano, et al.
Publicado: (2021) -
Skin AGEs and diabetic neuropathy
por: Papachristou, Stella, et al.
Publicado: (2021) -
COVID-19 and the kidney: time to take a closer look
por: Liakopoulos, Vassilios, et al.
Publicado: (2021)